Table 1 Comparison of characteristics and outcomes between the complication groups
From: Factors that may affect the outcome of acute occlusive mesenteric ischemia. A single-center study
Normal group n = 42 | Complication group n = 17 | P | |
|---|---|---|---|
Sex, male (n, %) | 28, 66.70% | 12, 70.60% | 0.77 |
Age (year, mean ± SD) | 62.64 ± 16.45 | 67.94 ± 15.89 | 0.26 |
Diagnosis | 0.14 | ||
EAMI (n, %) | 13, 31.00% | 10, 58.80% | |
TAMI (n, %) | 9, 21.40% | 2, 11.80% | |
VAMI (n, %) | 20, 47.60% | 5, 29.40% | |
Transmural intestinal necrosis (n, %) | 12, 28.60% | 14, 82.40% | < 0.01 |
Duration from onset to diagnosis (hours, Median, IQR) | 84, 148.50 | 49, 90.00 | 0.74 |
Duration from onset to diagnosis categories | 0.98 | ||
≤ 24 h (n, %) | 15, 35.70% | 6, 35.30% | |
> 24 h (n, %) | 27, 64.30% | 11, 64.70% | |
Duration from onset to treatment (hours, Median, IQR) | 98.75, 207.13 | 75.75, 140.13 | 0.91 |
Duration from onset to treatment categories | 0.38 | ||
≤ 24 h(n, %) | 8, 19.00% | 1, 5.90% | |
> 24 h (n, %) | 34, 81.00% | 16, 94.10% | |
Abdominal pain (n, %) | 41, 97.60% | 17, 100.00% | 1.00 |
Abdominal distension (n, %) | 28, 66.70% | 15, 88.20% | 0.17 |
Nausea (n, %) | 24, 57.10% | 13, 76.50% | 0.16 |
Vomiting (n, %) | 19, 45.20% | 12, 70.60% | 0.08 |
Hematemesis (n, %) | 3, 7.10% | 3, 17.60% | 0.46 |
Hematochezia (n, %) | 14, 33.30% | 7, 41.20% | 0.57 |
Diarrhea (n, %) | 5, 11.90% | 2, 11.80% | 1.00 |
Comorbidities (n, %) | 35, 83.30% | 16, 94.10% | 0.50 |
Peritonitis (n, %) | 12, 28.60% | 11, 64.70% | 0.01 |
Fever (n, %) | 12, 28.60% | 7, 41.20% | 0.35 |
WBC (109/L, Median, IQR) | 11.49, 7.70 | 14.87, 10.08 | 0.03 |
CRP (mg/L, Median, IQR) | 63, 113.37 | 47.18, 102.07 | 0.87 |
PLT(109/L, Median, IQR) | 210.50, 69.75 | 202, 83.75 | 0.51 |
HGB (mg/L, mean ± SD) | 130.98 ± 27.26 | 141.56 ± 24.10 | 0.13 |
N% (%,Median, IQR) | 82.60, 14.70 | 87.60, 12.02 | 0.03 |
L% (%,Median, IQR) | 9.95, 12.33 | 5.65, 8.13 | 0.03 |
NLR (Median, IQR) | 8.31, 13.42 | 16.20, 22.54 | 0.03 |
D-dimer (mg/L, Median, IQR) | 6.72, 11.58 | 5.73, 9.36 | 0.85 |
LDH(IU/L, Median, IQR) | 230.50, 36.50 | 254.50, 79.50 | 0.03 |
CK(IU/L, Median, IQR) | 100.50, 112.50 | 194, 248.75 | 0.26 |
CKMB(ng/mL, Median, IQR) | 1.71, 2.27 | 4.38, 5.39 | 0.02 |
MYO(ng/mL, Median, IQR) | 59.78,106.20 | 112.50, 125.84 | 0.12 |
CTNI(ng/mL, Median, IQR) | 0.14, 0.01 | 0.25, 0.09 | 0.02 |
LAC(mmol/L, Median, IQR) | 1.85, 0.90 | 2.20, 1.63 | 0.22 |
PH(Median, IQR) | 7.40, 0.06 | 7.42, 0.06 | 0.70 |
CTA | |||
Emboli or thrombus in vessel (n, %) | 42,100.00% | 17,100.00% | |
Decreased intestinal wall enhancement (n, %) | 14, 33.30% | 9, 52.90% | 0.16 |
Intestinal wall thickening (n, %) | 28, 66.70% | 13, 76.50% | 0.46 |
Pneumatosis intestinalis (n, %) | 0, 0.00% | 1, 5.90% | 0.29 |
Ascites (n, %) | 16, 38.10% | 9, 52.90% | 0.30 |
Surgical approach (n, %) | 35, 83.30% | 17,100.00% | 0.18 |
Endovascular surgery (n, %) | 21, 50.00% | 6, 35.30% | 0.30 |
Laparoscopic exploration (n, %) | 13, 31.00% | 11, 64.70% | 0.02 |
Open embolectomy (n, %) | 11, 26.20% | 14, 82.40% | <0.01 |
Enterostomy (n, %) | 9, 21.40% | 14, 82.40% | <0.01 |
Length of necrosis small bowel(cm, Median, IQR) | 0, 15.00 | 75, 187.50 | <0.01 |
Length of healthy small bowel(cm, Median, IQR) | 400, 0.00 | 325, 221.50 | <0.01 |
Surgical time(min, Median, IQR) | 105, 182.25 | 300, 94.25 | <0.01 |
Intraoperative blood loss(ml, Median, IQR) | 10, 98.00 | 50, 68.75 | 0.01 |